Literature DB >> 7019318

Serum agglutinins to Eubacterium and Peptostreptococcus species in Crohn's and other diseases.

F Wensinck, J P Van de Merwe.   

Abstract

Sera from patients suffering from Crohn's and other diseases and from healthy subjects were tested for agglutinins to anaerobic, gram-positive coccoid rods belonging to species of Eubacterium and Peptostreptococcus. Four strains labelled Eubacterium contortum (two strains), Eubacterium rectale and Peptostreptococcus productus were agglutinated by a higher percentage of sera from patients with Crohn's disease than from healthy subjects and from patients with liver and intestinal diseases (including ulcerative colitis), ankylosing spondylitis, granulomatous diseases, diseases of immunity and malignancies. The agglutinins were of the IgG and IgM classes and strain-specific; the titres were low. The results obtained with sera from patients with Crohn's disease and healthy people were subjected to discriminant analysis to estimate the probability, based on the combined results with the four strains, that a patient suffers from Crohn's disease. When sera giving an a posteriori probability greater than or equal to 0.95 (a priori probability = 0.5) were considered positive, the test with four strains had a sensitivity of 54% and a specificity of nearly 100%. The results with sera submitted for diagnosis showed that positive reactions in patients with a diagnosis apparently incompatible with Crohn's disease were within acceptable limits.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7019318      PMCID: PMC2134081          DOI: 10.1017/s0022172400069199

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  15 in total

1.  Escherichia coli antibodies in patients with inflammatory bowel disease.

Authors:  S Tabaqchali; D P O'Donoghue; K A Bettelheim
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

2.  Hyperglobulinaemia in liver disease.

Authors:  D R Triger; R Wright
Journal:  Lancet       Date:  1973-06-30       Impact factor: 79.321

3.  Diagnosis of Crohn's disease. A continuing source of error.

Authors:  N H Dyer; A M Dawson
Journal:  Br Med J       Date:  1970-03-21

4.  Rotavirus antibodies in Crohn's disease and ulcerative colitis.

Authors:  G De Groote; J Desmyter; G Vantrappen; C A Phillips
Journal:  Lancet       Date:  1977-06-11       Impact factor: 79.321

5.  Antibodies to gluten and reticulin in gastrointestinal diseases.

Authors:  K P Eterman; T E Feltkamp
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

6.  Immunological studies in human schistosomiasis. III. Immunoglobulin levels, antibodies, and delayed hypersensitivity.

Authors:  D Camus; Y Carlier; M Capron; J C Bina; J F Figueiredo; A Prata; A Capron
Journal:  Am J Trop Med Hyg       Date:  1977-05       Impact factor: 2.345

7.  Antibodies to Eubacterium and Peptostreptococcus species and the estimated probability of Crohn's disease.

Authors:  J P Van de Merwe; P I Schmitz; F Wensinck
Journal:  J Hyg (Lond)       Date:  1981-08

8.  Antibodies to maize in patients with Crohn's disease, ulcerative colitis and coeliac disease.

Authors:  I W Davidson; R S Lloyd; P J Whorwell; R Wright
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

9.  Antibodies detectable by counterimmunoelectrophoresis against Bacteroides antigens in serum of patients with inflammatory bowel disease.

Authors:  C J Helphingstine; D J Hentges; B J Campbell; J Butt; J T Barrett
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

10.  The faecal flora of patients with Crohn's disease.

Authors:  F Wensinck; P A Poppelaars-Kustermans; A M Schröder
Journal:  J Hyg (Lond)       Date:  1981-08
View more
  10 in total

1.  Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues.

Authors:  R S Walmsley; A Anthony; R Sim; R E Pounder; A J Wakefield
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

2.  Serological markers to differentiate between ulcerative colitis and Crohn's disease.

Authors:  M Oudkerk Pool; G Bouma; S G Meuwissen; B M von Blomberg; J P van de Merwe; W L Devillé; J C Fonk; A S Peña
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

3.  Agglutinins to bacteria as a discriminatory test in Crohn's disease.

Authors:  G F McCoy; T G Parks; W A Hanna; F Wensinck
Journal:  Ir J Med Sci       Date:  1984-04       Impact factor: 1.568

4.  A possible role of Eubacterium and Peptostreptococcus species in the aetiology of Crohn's disease.

Authors:  J P van de Merwe; G J Mol
Journal:  Antonie Van Leeuwenhoek       Date:  1980       Impact factor: 2.271

5.  Culturing and extraction of Coprococcus comes, absorption of serumagglutinins by soluble fractions and relation between agglutinins and antibodies in sera of patients with Crohn's disease.

Authors:  M P Hazenberg; A M Pennock-Schröder; J P van de Merwe
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

6.  Antibodies to Eubacterium and Peptostreptococcus species and the estimated probability of Crohn's disease.

Authors:  J P Van de Merwe; P I Schmitz; F Wensinck
Journal:  J Hyg (Lond)       Date:  1981-08

7.  Arthropathic properties of cell wall polymers from normal flora bacteria.

Authors:  S A Stimpson; R R Brown; S K Anderle; D G Klapper; R L Clark; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

8.  Induction in rats of serum agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species by the faecal flora from patients with Crohn's disease and healthy subjects.

Authors:  M P Hazenberg; J P Van de Merwe; L M Custers-Van Lieshout; A M Pennock-Schröder
Journal:  J Hyg (Lond)       Date:  1984-10

9.  The faecal flora of patients with Crohn's disease.

Authors:  F Wensinck; P A Poppelaars-Kustermans; A M Schröder
Journal:  J Hyg (Lond)       Date:  1981-08

Review 10.  The human faecal flora and Crohn's disease.

Authors:  J P van de Merwe
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.